Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
Tyrosine kinase inhibitors are known to cause pulmonary complications. We report a case of bosutinib related bilateral pleural effusions in a patient with chronic myeloid leukemia. Characteristics of the pleural fluid are presented. We also discuss other tyrosine kinase inhibitors induced pulmonary...
Main Authors: | Natalia I. Moguillansky, MD, Hafiz Abdul Moiz Fakih, MD, John R. Wingard, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007117300552 |
Similar Items
-
Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
by: Qiuying (Selina) Liu, et al.
Published: (2021-05-01) -
Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
by: Vineet Agrawal, et al.
Published: (2015-02-01) -
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
by: Raffaella Pasquale, et al.
Published: (2022-09-01) -
Transudative pleural effusion of malignant etiology: Rare but real
by: Lindsey Johnson, MD, et al.
Published: (2017-01-01) -
Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
by: Mario Tiribelli, et al.
Published: (2019-08-01)